Once upon a BCG vaccine
LA JOLLA—A long, long time ago, the BCG vaccine was approved for use against tuberculosis (TB), and it’s still
Roberta Nowak, lab manager extraordinaire
A "Lab Manager of the Year" finalist shares tips for keeping research running—and scientists happy
New vaccine ingredient shows promise
Most vaccines include particles called adjuvants. But not all adjuvants are created equal.
The genius of LJI
La Jolla Institute's "Top Workplaces" ranking proves the power of collaboration in advancing medical research
Suffering from psoriasis? Blame this trio of proteins
LA JOLLA—About 7.5 million Americans suffer from psoriasis, an autoimmune disease that shows up as patches of red, inflamed
COVID-19 case severity: How genetic differences leave immune cells at a disadvantage
New LJI research shows how a range of critical immune cells respond to SARS-CoV-2
Six LJI scientists named “Highly Cited Researchers”
The international recognition reflects how LJI research is valued by scientific peers
LJI graduate students win prestigious ARCS San Diego awards
ARCS support propels vaccine design and HIV research
When Alex Marki sets sail
After a long week in the lab, Sundays are for sailing
Erica Ollmann Saphire receives $2.6 million grant to collaborate on pan-coronavirus vaccine
La Jolla Institute scientists team up with Brigham and Women's Hospital to guide the development of vaccines against the coronavirus family
Finance leader Richard Stryjewski appointed CFO at La Jolla Institute for Immunology
LA JOLLA, CA—Richard Stryjewski, a financial leader with deep expertise in the non-profit research sector, has been appointed as
Why we give – Raydene and Peter St. Clair
Behind every “eureka!” science headline is a story of perseverance